The in3 project is funded by the EU’s Marie Sklodowska-Curie Action – Innovative Training Network (MSCA-ITN for short) that aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial (NM) safety assessment. Here are our dedicated, motivated, dynamic, early stage researchers.
Coordinator: Prof. Dr. Paul Jennings firstname.lastname@example.org
Training coordinator: Dr. Maxime Culot email@example.com
Project manager: Dr. Ellen Langemeijer firstname.lastname@example.org
in3 session ESTIV 2018 Berlin
in3 session Project Meetings and Training
- Rauch, C., Feifel, E., Kern, G., Murphy, C., Meier, F., Parson, W., Beilmann, M., Jennings, P., Gstraunthaler, G., Wilmes, A., 2018. Differentiation of human iPSCs into functional podocytes. PLoS One 13, e0203869. doi:10.1371/journal.pone.0203869/
|in3 is funded by the Marie Sklodowska-Curie Action – Innovative Training Network under grant no. 721975.|